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The enhanced incorporation of 32Pi into two minor acidic phospholipids, 
phosphatidate and phosphatidylinositol, is a response characteristic of  a number of 
effectors, including neurotransmitters and hormones, with their receptors on the cell 
membrane. In the nervous system, this is perhaps best documented in the case of 
acetylcholine action on brain synaptosomes, slices or on sympathetic ganglia (for re- 
view, see ref. 14). This 'phospholipid labeling effect' (PLE) appears to require tissue 
structural integrity since it is not observed in cell-free preparations. The PLE elicited 
by muscarinic agonists in nerve ending fractions 19 might be considered an exception. 
However, isolated synaptosomes retain considerable internal structure and metabolic 
viability, and as such may be considered as resealed anucleate neurons. Neurotrans- 
mitter receptors have traditionally been considered to be localized on the postsynaptic 
membrane, and a number of indirect approaches suggest that the neurotransmitter-di- 
rected PLE in pineal gland 21 and superior cervical ganglion 11 is associated with this 
site. In the case of synaptosomes, this conclusion is not readily made. For example, 
the assumption that added azPi must first be converted to y-32P-ATP before 
phospholipids can be labeled suggests that intrasynaptosomal oxidative phosphoryla- 
tion is an obligate step in the synaptosomal PLE (see ref. 19), an argument that would 
appear to favor a presynaptic localization. Furthermore, postsynaptic membranes are 
not prominent in the 'light' synaptosomal fraction shown to mediate the PLE in 
guinea pig brain fractions 2°. The case for a presynaptic site is however by no means 
conclusive. In a recent study, we concluded that calcium mobilization accompanies the 
muscarinic PLE (see ref. 5) in synaptosomes. The increase in calcium availability that 
parallels the PLE is at variance with the probable physiological role of presynaptic 
muscarinic receptors in cerebral cortex in reducing neurotransmitter release 1~,z2. by 
appearing to limit calcium availability 13. That  is, we would have anticipated that ac- 
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tivation of a presynaptic receptor would be mimicked by reducing rather than by 
increasing calcium flux. The observed calcium effect prompted us to re-examine the 
inferred localization of the cholinergic receptors responsible for the synaptosomal 
PLE. In this report, we have experimentally broached this question by examining the 
role of cholinergic innervation on the acetylcholine (ACh)-induced PLE in synaptoso- 
mes derived from the hippocampus. The hippocampus supports a robust PLE and its 
sole cholinergic input from the septal nuclei can be readily disrupted by the placement 
of lesions in the fornix. As discussed below, the lesion is expected to cause degenera- 
tion of cholinergic presynaptic fibers, but should have little effect on the integrity of 
postsynaptic structures, and thus provide a means of further localizing the synaptoso- 
mal PLE. 
Male guinea pigs (250-350 g) were anesthetized with pentobarbital (35 mg/kg) 
and placed in a stereotaxic frame (Kopf Instruments). Bilateral anodal electrolytic 
lesions of the fornix (0.5 mm posterior to bregma, 5.2 mm below brain surface and 1 
mm lateral to the midline) were effected by passing a current of 8 mA for 30 sec. Eight 
to ten days after surgery, the guinea pigs were killed by stunning and exsanguination, 
the overlying cortical structures displaced by means of a blunt spatula, and the 
hippocampal formation (including subiculum, dentate gyrus and hippocampus pro- 
per) from both sides removed. The hippocampal formation (150-240 mg wet weight) was 
homogenized in 6 ml of 0.32 M sucrose and a nerve ending fraction (P2B) prepared by 
conventional methods s. Lipid labeling from 32Pi in the absence and presence of ACh 
(10 -4 plus 10 -4 M eserine) was carried out by incubating aliquots of synaptosomes 
(200-400/~g protein) in a medium containing (final concentrations): 100 mM sodium 
glycylglycinate buffer (pH 7.4); 1 mM sodium pyruvate; 1 mM sodium fumarate; 1 
mM MgSO4; 0.5 mM CaC12; 0.1 mM NaH~PO4; and 60-150/zCi of 32p1 (carrier free) 
in a total vol. of 0.25 ml. Incubations were terminated after 45 min and lipids extracted 
and quantified essentially as described previously 2°. Choline acetyltransferase (CHAT) 
was determined by a radiochemical assay 6. Acetylcholinesterase (ACHE) activity was 
measured spectrophotometrically at 37 °C by the method of Ellman et al. 3, with the 
inclusion of 10 -5 M tetraisopropylpyrophosphoramide to inhibit pseudocholinesterase 
activity 12. The binding of [3H]-quinuclidinylbenzilate (QNB) was measured by incu- 
bating 40-160 pg of protein for 60 min at 25 °C in the presence of 1 nM QNB (29.4 
Ci/mmol) 25. Reactions were terminated by rapid vacuum filtration of assay compo- 
nents through glass fiber filters (Whatman GF/B). Specific binding is defined as total 
binding minus binding in the presence of 10 -6 M atropine. Glutamate decarboxylase 
(GAD) activity in synaptosomes (70-250 #g protein) was determined by measuring 
14CO2 evolution from sodium L-[l-14C]glutamate. Each incubation contained (final 
concentrations): 2 mM sodium L-glutamate (0.28 mCi/mmol); 50 mM sodium 
phosphate buffer (pH 6.8); l mM dithiothreitol; 0.2 mM pyridoxal-5'-phosphate; I0 
mg/ml BSA; 1 mM sodium arsenite and 0.5 ~ (v/v) Triton X-100 in a total vol. of 0.1 
ml. Reactions were terminated after 120 min and the 14CO2 evolved at 37 °C measured 
as described previously 4. Protein was determined by the method of Geiger and 
Bessman 7. Results are expressed as mean ± S.E.M. Student's t-tests were used to 
evaluate differences in means of sets of data. 
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In unlesioned control animals, the inclusion of 10 -4 M ACh stimulated the 
incorporation of a2Pi into both phosphatidate (PhA) and phosphatidylinositol (Phl) 
by 86 and 5 5 ~  respectively (Table I). Atropine (10 -5 M) completely blocked this 
stimulation of lipid labeling, while D-tubocurarine 0 0  -4 M) had no effect. This result 
is in accordance with our previous observations, and those of others, showing that the 
cholinergic PLE in cerebral cortex 19, caudate nucleus 1 and sympathetic ganglia 18 is 
muscarinic. 
The extent and nature of changes in both basal and stimulated lipid labeling 
were not significantly affected by interruption of the cholinergic input. Thus, after 
placement of fornix lesions, synaptosomai fractions from the hippocampus showed 
mean stimulations of PhA and Phi labeling of 76 and 41 ~ respectively, on addition of 
ACh (Table I). In marked contrast, the fornix lesions resulted in a large (72 ~o) 
reduction of CHAT, a presynaptic cholinergic marker enzyme 6, and a 56 ~o reduction 
of ACHE, an enzyme also considered to be presynaptic in the hippocampus 17,24. Since 
several animals showed an almost total loss of  ChAT activity, the partial loss 
following lesions is more likely to reflect an incomplete transection of fiber tracts, 
rather than the presence of a separate population of cholinergic neurons. The 
prevalence of muscarinic receptors present in the synaptosomal fraction, as determi- 
ned by [ZH]QNB binding, was unchanged following the lesion, which suggests that 
these synaptosomal muscarinic receptors are not present on cholinergic nerve endings. 
Although it is possible that a small population of presynaptic muscarinic receptors 
may exist within the hippocampus16, 27 it seems unlikely that they contribute signifi- 
cantly to the PLE. G A D  activity also remained unchanged after the fornix lesions, in- 
dicating that intrinsic GABAergic neurons had not been affected. 
TABLE I 
The effect of fornix lesions on the phospholipid labeling effect, marker enzymes and muscarinic receptor 
binding in synaptosomal fractions from hippocampus 
APhA and APhI refer to per cent stimulation of labeling from 32P1, by ACh. Units of measurement 
were as follows: CHAT, AChE and GAD: nmot/mg protein/min; QNB: pmol bound/mg protein; 
protein: mg/g wet weight. The numbers in parentheses refer to the number of separate experiments. 
Values for marker enzyme activities and QNB binding were also obtained for whole homogenates 
from both control and lesioned groups. These results indicated that alterations in the various para- 
meters after fornix lesions closely paralleled those in the nerve ending fraction. 
Control Lesioned 
APhA 86 ± 5 (12) 78 ± 4 (15) 
APhI 55 ± 6 (12) 42 i 6 (15) 
ChAT 1.52 3- 0.07 (12) 0.42 3- 0.06 (17)* 
AChE 71.2 ± 6.3 (9) 31.3 3- 4.8 (9)* 
QNB 0.98 3- 0.08 (11) 0.94 3- 0.06 (10) 
GAD 2.31:3- 0.15 (8) 2.22 3- 0.14 (13) 
Protein 10.3 3- 0.6 (15) 9.8 ± 0.2 (17) 
* Statistically different from control group, P < 0.001. All other comparisons were not significant 
at the P = 0.05 level. 
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The  dissocia t ion of  the  synap tosomal  P L E  f rom the septal  chol inergic  inpu t  
demons t ra tes  tha t  the  muscar in ic  receptors  coupled  to  s t imula ted  P h A  and  P h i  
tu rnover  are  present  on structures tha t  are  non-chol inergic  in origin.  Possible sites of  
local iza t ion o f  these chol inergic  receptors  include the dopaminerg ic ,  noradrenerg ic  or  
serotonergic  nerve endings shown to be chol inocept ive  in o ther  systems2,1°,13, or  on 
dendr i te -der ived  part icles  ( ' dendrosomes ' )L  
Whi le  we canno t  a t  present  unequivocal ly  ident i fy the m e m b r a n e  locus o f  the 
PLE,  the mos t  pa r s imonious  in te rpre ta t ion  of  our  results is tha t  in h i p p o c a m p a l  
synaptosomes,  and  by  inference, in b ra in  synap tosomes  in general ,  the PLE occurs in a 
s tructure tha t  is pos t synap t ic  to the physiologica l  site o f  the A C h  release. In  this  
respect,  the  pos t synap t ic  loca t ion  o f  the synap tosomal  PLE is in accord  with the  
inferred site of  s t imula ted  l ipid label ing observed in sympathe t ic  gangl ia  11 and  pineal  
g land 21. 
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